---
$id: https://graph.org.ai/products/commodity/51161518
$type: Product
source: UNSPSC
code: "51161518"
title: "Pranlukast"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pranlukast

**UNSPSC Code**: 51161518
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-asthmatic agent and leukotriene antagonist with the molecular formula C27H23N5O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TB8Z891092, chemically known as benzamide, n-(4-oxo-2-(1h-tetrazol-5-yl)-4h-1-benzopyran-8-yl)-4-(4-phenylbutoxy)- but generally known as pranlukast, which bears US NIH Compound Identifier 115100. European Medicines Agency schedules Pranlukast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09998MIG. World Health Organization schedules pranlukast in its Anatomical Therapeutic Chemical (ATC) Classification. PRANLUKAST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pranlukast under HS 29349990 and SITC 51579. As of Q4 2014, PRANLUKAST remains the US FDA Preferred Term for this commodity. Pranlukast bears US NLM identifiers UMLS ID C0526058 and NCI Concept Code C96712. SMILES: O(CCCCC1CCCCC1)C1CCC(CC1)C(=O)NC1CC2OC(CC(=O)C2CC1)C1N[NH]NN1.

